These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31209940)

  • 1. Chronic Acquired Polyneuropathy Patient Reported Index (CAPPRI) in chronic inflammatory demyelinating polyradiculoneuropathy.
    Bjelica B; Peric S; Gwathmey K; Sadjadi R; Bozovic I; Burns TM; Basta I
    J Peripher Nerv Syst; 2019 Sep; 24(3):247-252. PubMed ID: 31209940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Serbian version of inflammatory Rasch-built overall disability scale in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Peric S; Bozovic I; Pruppers MHJ; Bjelica B; Stevic Z; Faber CG; Merkies ISJ; Basta I
    J Peripher Nerv Syst; 2019 Sep; 24(3):260-267. PubMed ID: 31397933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric longitudinal evaluation of the Chronic Acquired Polyneuropathy Patient-Reported Index (CAPPRI) in patients with chronic inflammatory demyelinating polyneuropathy.
    Sadjadi R; Peric S; Gwathmey K; Bozovic I; Aleksa P; Bjelica B; Burns T; Basta I
    Muscle Nerve; 2021 Jan; 63(1):84-88. PubMed ID: 33043466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Bozovic I; Kacar A; Peric S; Nikolic A; Bjelica B; Cobeljic M; Petrovic M; Stojanov A; Djuric V; Stojanovic M; Djordjevic G; Martic V; Dominovic A; Vukojevic Z; Basta I
    J Neurol; 2017 Dec; 264(12):2481-2486. PubMed ID: 29086018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular disease-specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Kacar A; Bjelica B; Bozovic I; Peric S; Nikolic A; Cobeljic M; Petrovic M; Stojanov A; Djordjevic G; Vukojevic Z; Dominovic-Kovacevic A; Stojanovic M; Stevic Z; Rakocevic-Stojanovic V; Lavrnic D; Basta I
    J Peripher Nerv Syst; 2018 Mar; 23(1):11-16. PubMed ID: 29360221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year follow-up study of neuropathic pain in chronic inflammatory demyelinating polyradiculoneuropathy.
    Bjelica B; Peric S; Bozovic I; Kacar A; Cobeljic M; Dejanovic I; Stevic Z; Basta I
    J Peripher Nerv Syst; 2019 Jun; 24(2):180-186. PubMed ID: 30973184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy.
    Klehmet J; Tackenberg B; Haas J; Kieseier BC
    BMC Neurol; 2023 May; 23(1):207. PubMed ID: 37237267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group.
    Merkies IS; Schmitz PI; Samijn JP; van der Meché FG; van Doorn PA
    Neurology; 1999 Nov; 53(8):1648-54. PubMed ID: 10563607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Employment status of patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Bjelica B; Basta I; Bozovic I; Kacar A; Nikolic A; Dominovic-Kovacevic A; Vukojevic Z; Martic V; Stojanov A; Djordjevic G; Petrovic M; Stojanovic M; Peric S
    J Peripher Nerv Syst; 2018 Sep; 23(3):178-182. PubMed ID: 29999199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and determinants of pain in chronic inflammatory demyelinating polyneuropathy: Results from the German INHIBIT registry.
    Mork H; Motte J; Fisse AL; Grüter T; Brünger J; Stoykova Z; Bulut Y; Athanasopoulos D; Sturm D; Tegenthoff M; Gold R; Enax-Krumova E; Pitarokoili K
    Eur J Neurol; 2022 Jul; 29(7):2109-2120. PubMed ID: 35357725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective analysis of disability and quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Bozovic I; Peric M; Arsic Azanjac A; Palibrk A; Bulatovic I; Aleksic D; Peric S; Basta I
    Qual Life Res; 2021 Sep; 30(9):2573-2579. PubMed ID: 33830457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment and disability in 20 CIDP patients according to disease activity status.
    Panaite PA; Renaud S; Kraftsik R; Steck AJ; Kuntzer T
    J Peripher Nerv Syst; 2013 Sep; 18(3):241-6. PubMed ID: 24028192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of tremor on disability assessment in chronic inflammatory demyelinating polyradiculoneuropathy.
    van Veen R; Pallada G; Wieske L; Ten Holter SEM; van Rootselaar AF; Verhamme C; de Bie RMA; van Schaik IN; Merkies ISJ; Dijk JM; Eftimov F
    J Peripher Nerv Syst; 2023 Mar; 28(1):58-68. PubMed ID: 36571466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale.
    van Nes SI; Vanhoutte EK; Faber CG; Garssen M; van Doorn PA; Merkies IS;
    J Peripher Nerv Syst; 2009 Dec; 14(4):268-78. PubMed ID: 20021568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics, and impairment and disability scale scores for different CIDP Disease Activity Status classes.
    Alabdali M; Abraham A; Alsulaiman A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    J Neurol Sci; 2017 Jan; 372():223-227. PubMed ID: 28017218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in patients with polyneuropathy associated with different types of monoclonal gammopathy of undetermined significance.
    Opalic M; Peric S; Palibrk A; Bozovic I; Bjelica B; Stevic Z; Basta I
    Acta Neurol Belg; 2020 Oct; 120(5):1133-1138. PubMed ID: 31201672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Getting closer to patients: the INCAT Overall Disability Sum Score relates better to patients' own clinical judgement in immune-mediated polyneuropathies.
    Merkies IS; Schmitz PI
    J Neurol Neurosurg Psychiatry; 2006 Aug; 77(8):970-2. PubMed ID: 16549419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.
    Suanprasert N; Taylor BV; Klein CJ; Roforth MM; Karam C; Keegan BM; Dyck PJB
    Mult Scler Relat Disord; 2019 May; 30():284-290. PubMed ID: 30870805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensory chronic inflammatory demyelinating polyneuropathy: an under-recognized entity?
    Ayrignac X; Viala K; Koutlidis RM; Taïeb G; Stojkovic T; Musset L; Léger JM; Fournier E; Maisonobe T; Bouche P
    Muscle Nerve; 2013 Nov; 48(5):727-32. PubMed ID: 23424105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin.
    Cirillo G; Todisco V; Tedeschi G
    Clin Neurophysiol; 2018 May; 129(5):967-973. PubMed ID: 29554579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.